These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 26822794)
1. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner. Polansky JK; Bahri R; Divivier M; Duitman EH; Vock C; Goyeneche-Patino DA; Orinska Z; Bulfone-Paus S Sci Rep; 2016 Jan; 6():19699. PubMed ID: 26822794 [TBL] [Abstract][Full Text] [Related]
2. Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity. Tosic V; Thomas DL; Kranz DM; Liu J; McFadden G; Shisler JL; MacNeill AL; Roy EJ PLoS One; 2014; 9(10):e109801. PubMed ID: 25329832 [TBL] [Abstract][Full Text] [Related]
3. An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma. Ma R; Lu T; Li Z; Teng KY; Mansour AG; Yu M; Tian L; Xu B; Ma S; Zhang J; Barr T; Peng Y; Caligiuri MA; Yu J Cancer Res; 2021 Jul; 81(13):3635-3648. PubMed ID: 34006525 [TBL] [Abstract][Full Text] [Related]
4. The combination of NK and CD8+T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells. Ye JF; Qi WX; Liu MY; Li Y Cell Immunol; 2017 Aug; 318():35-41. PubMed ID: 28651743 [TBL] [Abstract][Full Text] [Related]
5. Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance. Doedens AL; Rubinstein MP; Gross ET; Best JA; Craig DH; Baker MK; Cole DJ; Bui JD; Goldrath AW Cancer Immunol Res; 2016 Sep; 4(9):799-811. PubMed ID: 27485135 [TBL] [Abstract][Full Text] [Related]
6. Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 Borrelli C; Ricci B; Vulpis E; Fionda C; Ricciardi MR; Petrucci MT; Masuelli L; Peri A; Cippitelli M; Zingoni A; Santoni A; Soriani A Cancer Immunol Res; 2018 Jul; 6(7):860-869. PubMed ID: 29691234 [TBL] [Abstract][Full Text] [Related]
7. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis]. Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773 [TBL] [Abstract][Full Text] [Related]
8. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells. Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977 [TBL] [Abstract][Full Text] [Related]
10. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma. Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein. Ng S; Deng J; Chinnadurai R; Yuan S; Pennati A; Galipeau J Cancer Res; 2016 Oct; 76(19):5683-5695. PubMed ID: 27488533 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models. Rhode PR; Egan JO; Xu W; Hong H; Webb GM; Chen X; Liu B; Zhu X; Wen J; You L; Kong L; Edwards AC; Han K; Shi S; Alter S; Sacha JB; Jeng EK; Cai W; Wong HC Cancer Immunol Res; 2016 Jan; 4(1):49-60. PubMed ID: 26511282 [TBL] [Abstract][Full Text] [Related]
13. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620 [TBL] [Abstract][Full Text] [Related]
14. CD226 interaction with CD155 impacts on retention and negative selection of CD8 positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's Patches. Danisch S; Qiu Q; Seth S; Ravens I; Dorsch M; Shibuya A; Shibuya K; Förster R; Bernhardt G Immunobiology; 2013 Feb; 218(2):152-8. PubMed ID: 22429743 [TBL] [Abstract][Full Text] [Related]
15. Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering. Ruedl C; Hubele S Eur J Immunol; 1997 Jun; 27(6):1325-30. PubMed ID: 9209480 [TBL] [Abstract][Full Text] [Related]